Status:
COMPLETED
STN-Stimulation Versus Best Medical Treatment in Advanced PD
Lead Sponsor:
German Parkinson Study Group (GPS)
Conditions:
Parkinson's Disease
Eligibility:
All Genders
20-75 years
Phase:
PHASE3
Brief Summary
Assessment of the therapeutic effect of deep brain stimulation of the subthalamic nucleus compared with drug treatment alone in patients with advanced Parkinson's disease.
Detailed Description
Patients are randomized either to medical treatment or subthalamic stimulation. The observation period was 6 months. The primary outcome criterium: PDQ-39 and UPDRS III.
Eligibility Criteria
Inclusion
- advanced Parkinson's disease with UPDRS III score \>29/104 or Dyskinesia score \> 2 or tremor \>2
Exclusion
- age\>75 years depression psychosis surgical contraindications
Key Trial Info
Start Date :
January 1 2001
Trial Type :
INTERVENTIONAL
End Date :
January 1 2005
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT00196911
Start Date
January 1 2001
End Date
January 1 2005
Last Update
November 30 2006
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Neurologische Klinik der Charité, Augustenburgerplatz 1
Berlin, Germany, 13353
2
Neurologische Klinik der Universität, Gleuelerstr. 50
Cologne, Germany, 50931
3
Neurologische Klinik der Universität, Moorenstr. 5
Düsseldorf, Germany, 40225
4
Neurologische Klinik der Universität, Neuenheimerfeld 400
Heidelberg, Germany, 69120